Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO group
Background: Immune checkpoint inhibitors (ICIs) have reshaped the treatment landscape for metastatic urothelial carcinoma (mUC), yet reliable predictive biomarkers remain limited. The SamUR-AI study was designed to evaluate whether machine learning (ML) and explainable artificial intelligence (XAI)...
में बचाया:
| मुख्य लेखकों: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Elsevier
2026-03-01
|
| श्रृंखला: | ESMO Real World Data and Digital Oncology |
| विषय: | |
| ऑनलाइन पहुंच: | http://www.sciencedirect.com/science/article/pii/S2949820125005703 |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
